The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street’s estimates seem disconnected from reality and some better opportunities to consider.

Redwire (RDW)

Consensus Price Target: $13.50 (21.2% implied return)

Based in Jacksonville, Florida, Redwire (NYSE: RDW) is a provider of systems and components used in space infrastructure.

Why Are We Wary of RDW?

1. Historically negative EPS is a worrisome sign for conservative investors and obscures its long-term earnings potential
2. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 28.2 percentage points
3. Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution

Redwire is trading at $11.14 per share, or 1,649.4x forward EV-to-EBITDA. Check out our free in-depth research report to learn more about why RDW doesn’t pass our bar.

Silgan Holdings (SLGN)

Consensus Price Target: $54 (32.3% implied return)

Established in 1987, Silgan Holdings (NYSE: SLGN) is a supplier of rigid packaging for consumer goods products, specializing in metal containers, closures, and plastic packaging.

Why Are We Out on SLGN?

1. Sales trends were unexciting over the last two years as its 4.1% annual growth was below the typical industrials company
2. Projected sales growth of 2.6% for the next 12 months suggests sluggish demand
3. Gross margin of 16.8% is below its competitors, leaving less money to invest in areas like marketing and R&D

At $40.81 per share, Silgan Holdings trades at 10.8x forward P/E. Read our free research report to see why you should think twice about including SLGN in your portfolio.

U.S. Physical Therapy (USPH)

Consensus Price Target: $104 (33% implied return)

With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE: USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.

Why Do We Think Twice About USPH?

1. Modest revenue base of $781 million gives it less fixed cost leverage and fewer distribution channels than larger companies
2. Incremental sales over the last five years were less profitable as its 1.9% annual earnings per share growth lagged its revenue gains
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 6 percentage points

U.S. Physical Therapy’s stock price of $78.19 implies a valuation ratio of 26.6x forward P/E. To fully understand why you should be careful with USPH, check out our full research report (it’s free).

Stocks We Like More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.